Apexigen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.07 million compared to USD 28.92 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.6 a year ago.
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |